We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

115 hedge funds and large institutions have $147M invested in VanEck Biotech ETF in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 23 increasing their positions, 35 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

321% more call options, than puts

Call options by funds: $1.02M | Put options by funds: $243K

0.2% more ownership

Funds ownership: 30.44% → 30.64% (+0.2%)

9% less funds holding

Funds holding: 126 → 115 (-11)

14% less capital invested

Capital invested by funds: $171M → $147M (-$23.5M)

34% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 35

38% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 21

Holders
115
Holders Change
-11
Holders Change %
-8.73%
% of All Funds
1.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
23
Reduced
35
Closed
21
Calls
$1.02M
Puts
$243K
Net Calls
+$781K
Net Calls Change
+$2.1M

Top Buyers

Rank Fund Capital Flow
1
TIA
Traphagen Investment Advisors
New Jersey
+$8.97M
2
CIG
Consolidated Investment Group
Colorado
+$2.92M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.47M
4
CCA
Conservest Capital Advisors
Pennsylvania
+$1.85M
5
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
+$1.69M

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$9.88M
2
Morgan Stanley
Morgan Stanley
New York
-$2.7M
3
Chevy Chase Trust
Chevy Chase Trust
Maryland
-$2.61M
4
FFN
Focus Financial Network
Minnesota
-$2.15M
5
CIBC Private Wealth Group
CIBC Private Wealth Group
Georgia
-$1.23M
Name Holding Trade Value Shares
Change 		Change in
Stake
TSWM
76
Tyler-Stone Wealth Management
Ohio
$133K – – –
Northwestern Mutual Wealth Management
77
Northwestern Mutual Wealth Management
Wisconsin
$83K -$33.8K -209 -29%
KTC
78
Kistler-Tiffany Companies
Pennsylvania
$77K – – –
TRCT
79
Tower Research Capital (TRC)
New York
$74K -$264K -1,633 -78%
William Blair & Company
80
William Blair & Company
Illinois
$69K -$1.3K -8 -2%
CT
81
Caldwell Trust
Florida
$68.9K – – –
NSIM
82
North Star Investment Management
Illinois
$67K – – –
CAL
83
Capital Analysts LLC
Pennsylvania
$66K – – –
CPFP
84
Clear Perspectives Financial Planning
Ohio
$65K – – –
FAG
85
Fortitude Advisory Group
Washington
$64K +$23.5K +145 +58%
EIP
86
Ellis Investment Partners
Pennsylvania
$56K – – –
FDCDDQ
87
Federation des caisses Desjardins du Quebec
Quebec, Canada
$48.6K – – –
KPCM
88
Kings Point Capital Management
New York
$44K – – –
AF
89
Arrow Financial
New York
$41K – – –
First Manhattan
90
First Manhattan
New York
$32K -$32.4K -200 -50%
AIM
91
Anchor Investment Management
South Carolina
$26.8K – – –
US Bancorp
92
US Bancorp
Minnesota
$24K – – –
EDRH
93
Edmond de Rothschild Holding
Switzerland
$21K – – –
AF
94
Allworth Financial
California
$20K -$5.18K -32 -21%
Carson Wealth (CWM LLC)
95
Carson Wealth (CWM LLC)
Nebraska
$19K – – –
Fidelity Investments
96
Fidelity Investments
Massachusetts
$18K -$2.43K -15 -12%
LWA
97
Lenox Wealth Advisors
New York
$17K – – –
CG
98
Cutler Group
California
$16K -$16.2K -100 -50%
M
99
MOTCO
Texas
$16K – – –
WT
100
Whittier Trust
California
$16K – – –
2 3
4
5 6

BBH Hedge Fund Activity: Q1 2022 in Review

115 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q1 2022, worth a combined $147M — down 14% from $171M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of BBH and 13 opened new positions — a net loss of 8 holders — while 35 trimmed existing stakes and 23 added.

The largest buyer was Traphagen Investment Advisors, adding an estimated $8.97M. The largest seller was Bank of America, cutting an estimated $9.88M.

  • 115 institutional investors held VanEck Biotech ETF (BBH) as of Q1 2022, down from 126 in Q4 2021.
  • Funds reported $147M of VanEck Biotech ETF stock for Q1 2022, down 14% quarter-over-quarter.
  • 13 funds opened new VanEck Biotech ETF positions in Q1 2022 and 21 closed out, a net change of -8 holders.
  • The largest VanEck Biotech ETF buyer in Q1 2022 was Traphagen Investment Advisors, an estimated $8.97M added.
  • The largest VanEck Biotech ETF seller in Q1 2022 was Bank of America, an estimated $9.88M sold.

Based on aggregated 13F filings for Q1 2022.